{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:20:08Z","timestamp":1784632808891,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960857"],"award-info":[{"award-number":["81960857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jep.2023.116684","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T21:02:13Z","timestamp":1684875733000},"page":"116684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPAR\u03b3-LXR\u03b1\/\u03b2-ABCA1 pathway"],"prefix":"10.1016","volume":"315","author":[{"given":"Jing","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-5341","authenticated-orcid":false,"given":"Yunzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jep.2023.116684_bib1","first-page":"1072","article-title":"Guide for the care and use of laboratory animals","volume":"103","author":"Alleva","year":"1997","journal-title":"Ethology"},{"key":"10.1016\/j.jep.2023.116684_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154554","article-title":"The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): a nationwide Cohort Study","volume":"109","author":"Bai","year":"2023","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.jep.2023.116684_bib3","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bjorkegren","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jep.2023.116684_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.119.315833","article-title":"Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses","volume":"125","author":"Chen","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.jep.2023.116684_bib5","article-title":"QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jep.2023.116684_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/CIRCRESAHA.110.233775","article-title":"Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways","volume":"108","author":"Chinetti-Gbaguidi","year":"2011","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.jep.2023.116684_bib7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/gast.2001.23250","article-title":"ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism","volume":"120","author":"Drobnik","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jep.2023.116684_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/pr.119.017897","article-title":"Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment","volume":"72","author":"Frambach","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jep.2023.116684_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104386","article-title":"Effects and mechanisms of QiShenYiQi pills and major ingredients on myocardial microcirculatory disturbance, cardiac injury and fibrosis induced by ischemia-reperfusion","volume":"147","author":"Han","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.jep.2023.116684_bib10","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1073\/pnas.1322153111","article-title":"Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes","volume":"111","author":"Hayashi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7611","key":"10.1016\/j.jep.2023.116684_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature18628","article-title":"TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis","volume":"535","author":"Hsieh","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jep.2023.116684_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/ATVBAHA.113.302781","article-title":"Activation of liver X receptor decreases atherosclerosis in Ldlr(-)\/(-) mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells","volume":"34","author":"Kappus","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.jep.2023.116684_bib13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.112.000588","article-title":"Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice","volume":"127","author":"Khan","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jep.2023.116684_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","article-title":"Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates","volume":"2","author":"Lameijer","year":"2018","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"10.1016\/j.jep.2023.116684_bib15","article-title":"A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jep.2023.116684_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jep.2023.116684_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113325","article-title":"Qishen Yiqi Dropping Pill facilitates post-stroke recovery of motion and memory loss by modulating ICAM-1-mediated neuroinflammation","volume":"153","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"47","key":"10.1016\/j.jep.2023.116684_bib18","doi-asserted-by":"crossref","first-page":"82196","DOI":"10.18632\/oncotarget.19072","article-title":"QiShenYiQi pill attenuates atherosclerosis by promoting regulatory T cells, inhibiting T helper 17 cells and accelerating cholesterol excretion","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jep.2023.116684_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/385154","article-title":"Effects of astragaloside IV on the SDF-1\/CXCR4 expression in atherosclerosis of apoE(-\/-) mice induced by hyperlipaemia","author":"Qin","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"issue":"23","key":"10.1016\/j.jep.2023.116684_bib20","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.18632\/aging.102498","article-title":"Mangiferin promotes macrophage cholesterol efflux and protects against atherosclerosis by augmenting the expression of ABCA1 and ABCG1","volume":"11","author":"Ren","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"10.1016\/j.jep.2023.116684_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jep.2023.116684_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2023.116684_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/738391","article-title":"Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial","author":"Shang","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"issue":"8","key":"10.1016\/j.jep.2023.116684_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.jep.2023.116684_bib25","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.7150\/thno.26193","article-title":"Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARgamma-LXRalpha-ABCA1\/ABCG1 pathway and promotes cholesterol efflux in advanced plaque","volume":"8","author":"Wang","year":"2018","journal-title":"Theranostics"},{"issue":"5\u20136","key":"10.1016\/j.jep.2023.116684_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1365\/s10337-010-1677-8","article-title":"Global chemome study by LC coupled with DAD and ESI-Q-TOF MS of a composite traditional Chinese medicine qishenyiqi dropping pills","volume":"72","author":"Wang","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.jep.2023.116684_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.02.013","article-title":"HDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b\/PPARgamma\/NF-kappaB axis","volume":"323","author":"Wang","year":"2021","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.jep.2023.116684_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/pca.3037","article-title":"Establishment and validation of the quantitative analysis of multi-components by single marker for the quality control of Qishen Yiqi dripping pills by high-performance liquid chromatography with charged aerosol detection","volume":"32","author":"Wu","year":"2021","journal-title":"Phytochem. Anal."},{"issue":"4","key":"10.1016\/j.jep.2023.116684_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110298","article-title":"Structure and transport mechanism of the human cholesterol transporter ABCG1","volume":"38","author":"Xu","year":"2022","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.jep.2023.116684_bib30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/ijms19041260","article-title":"The role of PPAR and its cross-talk with CAR and LXR in obesity and atherosclerosis","volume":"19","author":"Xu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jep.2023.116684_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2015.04.122","article-title":"Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux by targeting PPAR-gamma and LXRalpha","volume":"462","author":"Yue","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2023.116684_bib32","article-title":"Ginsenoside rg1-notoginsenoside R1-protocatechuic aldehyde reduces atherosclerosis and attenuates low-shear stress-induced vascular endothelial cell dysfunction","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2023.116684_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105639","article-title":"Yin-xing-tong-mai decoction attenuates atherosclerosis via activating PPARgamma-LXRalpha-ABCA1\/ABCG1 pathway","volume":"169","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"18","key":"10.1016\/j.jep.2023.116684_bib34","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/CIRCULATIONAHA.111.086041","article-title":"Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis","volume":"126","author":"Zhou","year":"2012","journal-title":"Circulation"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123005524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123005524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:38:04Z","timestamp":1759945084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874123005524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"alternative-id":["S0378874123005524"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2023.116684","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPAR\u03b3-LXR\u03b1\/\u03b2-ABCA1 pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2023.116684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116684"}}